Intragenic Antimicrobial Peptides (IAPs) synergize with plant alkaloids, reducing MICs up to 128-fold against MDR bacteria.
Background
The escalating crisis of multidrug-resistant (MDR) microorganisms causing nosocomial infections poses a severe global public health threat. Traditional antibiotics are increasingly ineffective due to widespread resistance, necessitating novel therapeutic strategies. Antimicrobial peptides (AMPs), including intragenic antimicrobial peptides (IAPs), offer a promising avenue due to their potent, broad-spectrum activity and lower propensity for resistance development. This study explores the synergistic potential of combining these peptides with plant alkaloids to overcome current limitations in treating persistent bacterial infections.
Study Design
Researchers evaluated the synergistic potential of intragenic antimicrobial peptides (IAPs) Hs02 and Gr01 combined with plant alkaloids berberine, tomatidine, and sinomenine. They performed Minimum Inhibitory Concentration (MIC) and Minimum Microbicidal Concentration (MMC) assays against both ATCC strains (E. coli ATCC 25922, S. aureus ATCC 25923) and clinical strains (E. coli KPC+ HRAN 1812446, S. aureus MDR LACEN 3730529). Synergistic interactions were quantified using a checkerboard assay, followed by biofilm inhibition and hemolysis assays using human red blood cells to assess toxicity.
Results
Individually, berberine exhibited a MIC of 1024 µM, while tomatidine and sinomenine showed no significant standalone activity. As anticipated, the IAPs demonstrated strong antimicrobial properties, with Hs02 achieving activity at 8 µM and Gr01 at 4 µM. When tested in synergy, the combinations of alkaloids and IAPs dramatically reduced the MIC by up to 128-fold, highlighting a potent synergistic effect. This significant reduction was observed across both susceptible and multidrug-resistant bacterial strains. > The combination of IAPs and alkaloids reduced the biofilm biomass of both S. aureus and E. coli by 50%, as measured by the crystal violet assay (p < 0.05). Notably, sinomenine was identified to possess antimicrobial activity, a property not previously reported for this alkaloid.
Key Findings
- IAPs Hs02 and Gr01 showed strong antimicrobial activity at 8 µM and 4 µM, respectively.
- Combinations of IAPs and alkaloids reduced
MICvalues by up to 128-fold against resistant bacteria. - Biofilm biomass of
S. aureusandE. coliwas reduced by 50% (p < 0.05) with synergistic combinations. - Sinomenine demonstrated previously unreported antimicrobial activity when combined with IAPs.
Why It Matters
This research highlights a promising new strategy for combating multidrug-resistant bacterial infections by combining natural plant alkaloids with synthetic intragenic antimicrobial peptides. For biohackers and clinicians, this suggests future protocols might leverage such combinations to enhance efficacy and potentially lower effective doses of individual agents, thereby reducing toxicity and extending the lifespan of existing antimicrobials. The discovery of novel antimicrobial activity in sinomenine also opens doors for further exploration of underutilized natural compounds. While currently preclinical, this approach could lead to new antimicrobial candidates that are more effective against resistant pathogens, potentially impacting treatment for nosocomial infections and other severe bacterial diseases.
antimicrobial-peptides
multidrug-resistance
berberine
sinomenine
hs02
gr01